Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 14, 2016; 22(6): 2092-2103
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2092
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2092
Figure 2 Western blot detection of urokinase plasminogen activator protein expression in bone marrow-derived mesenchymal stem cells after Ad- urokinase plasminogen activator transfection.
Lane 1, uninfected bone marrow-derived mesenchymal stem cells (BMSCs); Lane 2, BMSCs infected with recombinant adenovirus containing human urokinase plasminogen activator (uPA) cDNA; Lane 3, BMSCs infected with control adenovirus. GAPDH: Glyceraldehyde 3-phosphate dehydrogenase.
- Citation: Ma ZG, Lv XD, Zhan LL, Chen L, Zou QY, Xiang JQ, Qin JL, Zhang WW, Zeng ZJ, Jin H, Jiang HX, Lv XP. Human urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathway. World J Gastroenterol 2016; 22(6): 2092-2103
- URL: https://www.wjgnet.com/1007-9327/full/v22/i6/2092.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i6.2092